Cargando…
A Scorpion Defensin BmKDfsin4 Inhibits Hepatitis B Virus Replication in Vitro
Hepatitis B virus (HBV) infection is a major worldwide health problem which can cause acute and chronic hepatitis and can significantly increase the risk of liver cirrhosis and primary hepatocellular carcinoma (HCC). Nowadays, clinical therapies of HBV infection still mainly rely on nucleotide analo...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4885039/ https://www.ncbi.nlm.nih.gov/pubmed/27128943 http://dx.doi.org/10.3390/toxins8050124 |
_version_ | 1782434457368657920 |
---|---|
author | Zeng, Zhengyang Zhang, Qian Hong, Wei Xie, Yingqiu Liu, Yun Li, Wenxin Wu, Yingliang Cao, Zhijian |
author_facet | Zeng, Zhengyang Zhang, Qian Hong, Wei Xie, Yingqiu Liu, Yun Li, Wenxin Wu, Yingliang Cao, Zhijian |
author_sort | Zeng, Zhengyang |
collection | PubMed |
description | Hepatitis B virus (HBV) infection is a major worldwide health problem which can cause acute and chronic hepatitis and can significantly increase the risk of liver cirrhosis and primary hepatocellular carcinoma (HCC). Nowadays, clinical therapies of HBV infection still mainly rely on nucleotide analogs and interferons, the usage of which is limited by drug-resistant mutation or side effects. Defensins had been reported to effectively inhibit the proliferation of bacteria, fungi, parasites and viruses. Here, we screened the anti-HBV activity of 25 scorpion-derived peptides most recently characterized by our group. Through evaluating anti-HBV activity and cytotoxicity, we found that BmKDfsin4, a scorpion defensin with antibacterial and Kv1.3-blocking activities, has a comparable high inhibitory rate of both HBeAg and HBsAg in HepG2.2.15 culture medium and low cytotoxicity to HepG2.2.15. Then, our experimental results further showed that BmKDfsin4 can dose-dependently decrease the production of HBV DNA and HBV viral proteins in both culture medium and cell lysate. Interestingly, BmKDfsin4 exerted high serum stability. Together, this study indicates that the scorpion defensin BmKDfsin4 also has inhibitory activity against HBV replication along with its antibacterial and potassium ion channel Kv1.3-blocking activities, which shows that BmKDfsin4 is a uniquely multifunctional defensin molecule. Our work also provides a good molecule material which will be used to investigate the link or relationship of its antiviral, antibacterial and ion channel–modulating activities in the future. |
format | Online Article Text |
id | pubmed-4885039 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-48850392016-05-31 A Scorpion Defensin BmKDfsin4 Inhibits Hepatitis B Virus Replication in Vitro Zeng, Zhengyang Zhang, Qian Hong, Wei Xie, Yingqiu Liu, Yun Li, Wenxin Wu, Yingliang Cao, Zhijian Toxins (Basel) Article Hepatitis B virus (HBV) infection is a major worldwide health problem which can cause acute and chronic hepatitis and can significantly increase the risk of liver cirrhosis and primary hepatocellular carcinoma (HCC). Nowadays, clinical therapies of HBV infection still mainly rely on nucleotide analogs and interferons, the usage of which is limited by drug-resistant mutation or side effects. Defensins had been reported to effectively inhibit the proliferation of bacteria, fungi, parasites and viruses. Here, we screened the anti-HBV activity of 25 scorpion-derived peptides most recently characterized by our group. Through evaluating anti-HBV activity and cytotoxicity, we found that BmKDfsin4, a scorpion defensin with antibacterial and Kv1.3-blocking activities, has a comparable high inhibitory rate of both HBeAg and HBsAg in HepG2.2.15 culture medium and low cytotoxicity to HepG2.2.15. Then, our experimental results further showed that BmKDfsin4 can dose-dependently decrease the production of HBV DNA and HBV viral proteins in both culture medium and cell lysate. Interestingly, BmKDfsin4 exerted high serum stability. Together, this study indicates that the scorpion defensin BmKDfsin4 also has inhibitory activity against HBV replication along with its antibacterial and potassium ion channel Kv1.3-blocking activities, which shows that BmKDfsin4 is a uniquely multifunctional defensin molecule. Our work also provides a good molecule material which will be used to investigate the link or relationship of its antiviral, antibacterial and ion channel–modulating activities in the future. MDPI 2016-04-27 /pmc/articles/PMC4885039/ /pubmed/27128943 http://dx.doi.org/10.3390/toxins8050124 Text en © 2016 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Zeng, Zhengyang Zhang, Qian Hong, Wei Xie, Yingqiu Liu, Yun Li, Wenxin Wu, Yingliang Cao, Zhijian A Scorpion Defensin BmKDfsin4 Inhibits Hepatitis B Virus Replication in Vitro |
title | A Scorpion Defensin BmKDfsin4 Inhibits Hepatitis B Virus Replication in Vitro |
title_full | A Scorpion Defensin BmKDfsin4 Inhibits Hepatitis B Virus Replication in Vitro |
title_fullStr | A Scorpion Defensin BmKDfsin4 Inhibits Hepatitis B Virus Replication in Vitro |
title_full_unstemmed | A Scorpion Defensin BmKDfsin4 Inhibits Hepatitis B Virus Replication in Vitro |
title_short | A Scorpion Defensin BmKDfsin4 Inhibits Hepatitis B Virus Replication in Vitro |
title_sort | scorpion defensin bmkdfsin4 inhibits hepatitis b virus replication in vitro |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4885039/ https://www.ncbi.nlm.nih.gov/pubmed/27128943 http://dx.doi.org/10.3390/toxins8050124 |
work_keys_str_mv | AT zengzhengyang ascorpiondefensinbmkdfsin4inhibitshepatitisbvirusreplicationinvitro AT zhangqian ascorpiondefensinbmkdfsin4inhibitshepatitisbvirusreplicationinvitro AT hongwei ascorpiondefensinbmkdfsin4inhibitshepatitisbvirusreplicationinvitro AT xieyingqiu ascorpiondefensinbmkdfsin4inhibitshepatitisbvirusreplicationinvitro AT liuyun ascorpiondefensinbmkdfsin4inhibitshepatitisbvirusreplicationinvitro AT liwenxin ascorpiondefensinbmkdfsin4inhibitshepatitisbvirusreplicationinvitro AT wuyingliang ascorpiondefensinbmkdfsin4inhibitshepatitisbvirusreplicationinvitro AT caozhijian ascorpiondefensinbmkdfsin4inhibitshepatitisbvirusreplicationinvitro AT zengzhengyang scorpiondefensinbmkdfsin4inhibitshepatitisbvirusreplicationinvitro AT zhangqian scorpiondefensinbmkdfsin4inhibitshepatitisbvirusreplicationinvitro AT hongwei scorpiondefensinbmkdfsin4inhibitshepatitisbvirusreplicationinvitro AT xieyingqiu scorpiondefensinbmkdfsin4inhibitshepatitisbvirusreplicationinvitro AT liuyun scorpiondefensinbmkdfsin4inhibitshepatitisbvirusreplicationinvitro AT liwenxin scorpiondefensinbmkdfsin4inhibitshepatitisbvirusreplicationinvitro AT wuyingliang scorpiondefensinbmkdfsin4inhibitshepatitisbvirusreplicationinvitro AT caozhijian scorpiondefensinbmkdfsin4inhibitshepatitisbvirusreplicationinvitro |